Bio-Thera Solutions Ltd (688177)

Currency in CNY
30.98
-0.02(-0.07%)
Delayed Data·

688177 Financial Summary

Key Ratios

P/E Ratio-25.28
Price/Book19.95
Debt / Equity114.15%
Return on Equity-56.74%
Dividend Yield0.00%
EBITDA-454.21M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 31.00
(+0.06% Upside)

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
-0.23 / --
Revenue / Forecast
206.56M / --
EPS Revisions
Last 90 days

FAQ

What were Bio-Thera Solutions's earnings for the latest quarter?

The Bio-Thera Solutions EPS (TTM) is -1.17. Bio-Thera Solutions reported sales of 206.56, net income of -93.33, and EPS of -0.23 for the latest quarter.

What was Bio-Thera Solutions's net income for the latest quarter?

Bio-Thera Solutions's net income for the latest quarter was -93.33.

How did Bio-Thera Solutions's performance compare year-over-year in the latest quarter?

The company's revenue moved from 161.73 in the previous quarter to 206.56 in the latest quarter, and net income moved from -144.98 to -93.33 compared to the previous quarter.

What is Bio-Thera Solutions's net profit margin on a TTM basis?

Bio-Thera Solutions's trailing twelve months (TTM) net profit margin is -68.67%.

How does Bio-Thera Solutions's debt to equity ratio compare to industry standards?

Bio-Thera Solutions's total debt-to-equity ratio is 114.15%.

What is Bio-Thera Solutions's return on investment on a TTM basis?

Bio-Thera Solutions's trailing twelve months (TTM) return on investment (ROI) is -56.74%.

Did Bio-Thera Solutions gain or lose cash last quarter?

In the latest quarter, Bio-Thera Solutions's net change in cash was 208.92 million.

What were Bio-Thera Solutions's total assets and liabilities in the latest quarter?

As of the latest quarter, Bio-Thera Solutions reported total assets of 2,345.64 million and total liabilities of 1,198.62 million.

How has Bio-Thera Solutions's total revenue grown this year?

Bio-Thera Solutions's total revenue was 161.73 in the previous quarter and 206.56 in the latest quarter.

What is Bio-Thera Solutions's gross margin on a TTM basis?

Bio-Thera Solutions's trailing twelve months (TTM) gross margin is 70.99%.

What was Bio-Thera Solutions's revenue per share for the latest quarter?

Bio-Thera Solutions's revenue per share for the latest quarter was 7.32.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.